Chondroitin Sulfate Market Is Likely to Exhibit a CAGR of 3.3% Between 2017 and 2025
The global chondroitin sulfate market is anticipated to witness a sluggish growth in the coming years, as reported by Transparency Market Research (TMR). The vendors in the market are adopting the use of clinical trials for new products, which could give them a strategic advantage over their competitors. The industry is somewhat crippled with the recent identification of over-sulfated chondroitin sulfate as a heparin contaminant. Yet, vendors are being innovative in their approach.
View full press release